Original Article

Primary Sjögren’s syndrome as independent risk factor for subclinical atherosclerosis

Volume 9 · Issue 1 Publish Date: January 1, 2022
Full Text PDF
DOI
Marta Novella-Navarro
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
José Luis Cabrera-Alarcón
Bioinformatic Unit, GENOXPHOS-group Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
José Luis Rosales-Alexander
Department of Rheumatology, Hospiten Rambla, Santa Cruz de Tenerife, Spain
Jorge Juan González-Martín
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
Ofelia Carrión
Department of Vascular Surgery, Hospital Universitario Sanchinarro, Madrid, Spain
Paloma García de la Peña
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
Novella-Navarro, M., Cabrera-Alarcón, J. L., Rosales-Alexander, J. L., González-Martín, J. J., Carrión, O., & García de la Peña, P. (2022). Primary Sjögren’s syndrome as independent risk factor for subclinical atherosclerosis. European Journal of Rheumatology, 9(1), 20–25. https://doi.org/10.5152/eurjrheum.2021.20093
Full Text Full Text PDF

Abstract

Objective: To assess the prevalence of subclinical atherosclerosis in patients with primary Sjögren’s syndrome (pSS) and its possible association with clinical and analytical parameters of the disease.

Methods: In this cross-sectional study, 38 consecutive patients with pSS were compared with 38 age and sex healthy controls. Demographic variables and classic cardiovascular risk factors (CVRFs): Hypertension, dyslipidemia, diabetes mellitus, obesity, and smoking habit were assessed in both groups, and also disease-related features were collected in pSS group. The presence of subclinical atherosclerosis was assessed by carotid ultrasound, with carotid intima-media thickness (CIMT) measurement and determination of the presence of atheromatous plaques.

Results: Subclinical atherosclerosis presence was remarkably greater in patients with pSS than in healthy controls (OR = 4.17, 95%CI [1.27-16.54]), as well as CIMT values (0.79 ± 0.43mm vs. 0.66 ± 0.27mm; P = .02). No differences for classic CVRFs were found between both groups. An association of subclinical atherosclerosis with erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF) was observed in patients with pSS.

Conclusion: This cohort showed a greater prevalence of subclinical atherosclerosis in patients with pSS, indicating this disease as an independent risk factor for presence of early vascular damage.

Cite this article as: Novella-Navarro M, Cabrera-Alarcón JL, Rosales-Alexander JL, González-Martín JJ, Carrión O, García de la Peña P. Primary Sjögren’s syndrome as independent risk factor for subclinical atherosclerosis. Eur J Rheumatol. 2021;9(1):20-25.

Article Info
Published In
Journal European Journal of Rheumatology
Volume / Issue Volume 9 · Issue 1
Pages 20-25
History
Published Online January 1, 2022
Copyright
Affiliations
Marta Novella-Navarro
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
José Luis Cabrera-Alarcón
Bioinformatic Unit, GENOXPHOS-group Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
José Luis Rosales-Alexander
Department of Rheumatology, Hospiten Rambla, Santa Cruz de Tenerife, Spain
Jorge Juan González-Martín
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
Ofelia Carrión
Department of Vascular Surgery, Hospital Universitario Sanchinarro, Madrid, Spain
Paloma García de la Peña
Department of Rheumatology, Hospital Universitario Sanchinarro, Madrid, Spain
Cite this Article
Novella-Navarro, M., Cabrera-Alarcón, J. L., Rosales-Alexander, J. L., González-Martín, J. J., Carrión, O., & García de la Peña, P. (2022). Primary Sjögren’s syndrome as independent risk factor for subclinical atherosclerosis. European Journal of Rheumatology, 9(1), 20–25. https://doi.org/10.5152/eurjrheum.2021.20093
Share
Outlines